High production rates of stable drug-loadable microbubbles toward targetted, triggared drug delivery

S. A. Peyman, Radwa Abou-Saleh, Nicola Ingram, Gemma Marston, P. Louise Coletta, Stephen D. Evans*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Micron-sized bubbles of gas have been used commercially as contrast agents for ultrasound (US) for over 30 years. Recently interest has increased in combing the diagnostic imaging qualities of microbubbles (MBs) with drug delivery technology to produce new treatments for cancer. We have demonstrated a microfluidic device for producing drug-loaded MBs at high, clinically relevant concentrations (109 MB / mL) within 10 minutes. Currently, we report the potential for delivery of hydrophobic drugs by incorporating oil structures within the MB shell or attachment to the MB surface and in addition, an improvement in in vitro MB lifetime from 1 hour to over 5 hours at 37°C.

Original languageEnglish
Title of host publication17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013
PublisherChemical and Biological Microsystems Society
Pages521-523
Number of pages3
ISBN (Print)9781632666246
Publication statusPublished - 2013
Event17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013 - Freiburg, Germany
Duration: 27 Oct 201331 Oct 2013

Conference

Conference17th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2013
Abbreviated titleMicroTAS 2013
Country/TerritoryGermany
CityFreiburg
Period27/10/1331/10/13

Keywords

  • Drug delivery
  • Hydrophobic delivery
  • Microbubbles

ASJC Scopus subject areas

  • Bioengineering

Fingerprint

Dive into the research topics of 'High production rates of stable drug-loadable microbubbles toward targetted, triggared drug delivery'. Together they form a unique fingerprint.

Cite this